Replimune’s lead therapeutic candidate did not meet the two main goals of a study intended to support an FDA submission in cutaneous squamous cell carcinoma. But Replimune’s therapy, an oncolytic virus, has better data in melanoma, and the company plans a 2024 FDA submission in this skin cancer.
As virtual specialty care options continue to expand and access remains limited to dermatologists, Smart Health Innovation Lab announced this week that the platform, which allows people to do a full-body skin screening using a smartphone app, has joined the healthcare technology accelerator.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Only time will tell if a larger Phase III study will confirm data on a few dozen patients, but the two-drug combination appears to produce a higher complete response rate than than an existing doublet combination, without the associated toxicity.
The goal is to increase patient and physician awareness and education on clinical trials in dermatology and reduce the often time-consuming process of clinical trial recruitment.
SkinIO, a Chicago-based startup founded by Dr. Jean-Christophe Lapiere and Kyoko Crawford, uses technology to enable patients to monitor their skin health over time.
One of Sensus' essential benefits is that it doesn’t involve cutting, bleeding or stitching, and there is no need for anesthesia, no risk of infection or scarring and no need for reconstructive plastic surgery.
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
DermTech has a biopsy-free approach to test for melanoma - using an adhesive patch to collect skin cells and test if the RNA expression is consistent with cancer.
People are increasing their risk of melanoma by applying sunscreen to their bodies in patterns after the uncovered parts burn from the sun. #Sunburnart is trending on Twitter and Instagram.
Wearable devices are not just for tracking fitness and overall health. Some are providing much more specific information and recommendations.
San Diego skin cancer diagnostics startup DermTech is developing gene classifiers and expression tests to help more accurately screen for dermatologic issues. It just raised $2.4 million to do so, according to a regulatory filing – an interesting funding notice, given its announcement last year that it was readying for – and then withdrawing – a $25 […]
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
People who have a high risk of getting squamous cell carcinoma (the most common type of skin cancer) taking over-the-counter painkillers could actually be doing them a favor, according to a study published today in the Journal of Investigative Dermatology. Study co-author Catherine Olsen and her team, from QIMR Berghofer Medical Research Institute in Queensland, […]
If a doctor suspects a mole or skin spot might be cancerous, she would usually give the patient a local anesthetic, cut out or shave off a sample of the skin and send it to a lab for testing. With a new test being developed by biotechnology company DermTech, that sample could be taken without […]
LONDON (Reuters) - GlaxoSmithKline has filed for U.S. approval of a two-drug combination against melanoma earlier than many industry analysts expected, using data from a mid-stage clinical trial. The move highlights a growing belief among drug companie...